Lv1
30 积分 2024-08-20 加入
Influenza
2天前
已完结
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
5天前
已完结
Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates
10天前
已完结
Fluorescent virus lights up on a new drug for chronic hepatitis E
10天前
已完结
Precision-engineered STING agonist nanoparticles enable coordinated mucosal-systemic immunity for durable pan-β-coronavirus protection
11天前
已完结
Peginterferon alpha-2a add-on to siRNA JNJ-73763989 in untreated patients with HBeAg-positive chronic hepatitis B virus (HBV) infection: the phase 2 REEF-IT study
12天前
已完结
Artemisinin-Resistant Plasmodium falciparum in Africa
17天前
已完结
Therapeutic HBV vaccine efficacy through ancestral mismatched T cell epitopes
17天前
已完结
OS-030 Efficacy and safety of xalnesiran with and without an immunomodulator in virologically suppressed participants with chronic hepatitis B: end of study results from the phase 2, randomized, controlled, adaptive, open-label platform study (PIRANGA)
21天前
已完结
Functional anti-preS1 antibody responses associated with viral control in chronic hepatitis B
1个月前
已完结
皖公网安备34019202002308
